These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Reserpine: therapeutic use in schizophrenia; preliminary note]. MURATTI JB Dia Med; 1956 May; 28(33):880-3. PubMed ID: 13344248 [No Abstract] [Full Text] [Related]
4. The effect of reserpine on chronic schizophrenia. WODRASKA TW Med Times; 1955 Oct; 83(10):1029-33. PubMed ID: 13264900 [No Abstract] [Full Text] [Related]
5. Reserpine alone and as an adjunct to psychotherapy in the treatment of schizophrenia. COWDEN RC; ZAX M; SPROLES JA AMA Arch Neurol Psychiatry; 1955 Nov; 74(5):518-22. PubMed ID: 13268118 [No Abstract] [Full Text] [Related]
6. The use of reserpine (serpasil) in psychiatry. MCGRATH SD; RYAN JP; FENNELLY JJ J Ir Med Assoc; 1956 Jul; 39(229):1-4. PubMed ID: 13332310 [No Abstract] [Full Text] [Related]
7. Treatment of chronic schizophrenic reactions with reserpine. HOLLISTER LE; KRIEGER GE; KRINGEL A; ROBERTS RH Ann N Y Acad Sci; 1955 Apr; 61(1):92-100. PubMed ID: 14377276 [No Abstract] [Full Text] [Related]
8. Effects of chlorpromazine and reserpine in chronic schizophrenic patients. FREEMAN H; ARNOLD AL; CLINE HS Dis Nerv Syst; 1956 Jul; 17(7):213-9. PubMed ID: 13330613 [No Abstract] [Full Text] [Related]
9. The use of reserpine in shock-reversible patients and shock-resistant patients. TASHER DC; CHERMAK MW Ann N Y Acad Sci; 1955 Apr; 61(1):108-16. PubMed ID: 14377278 [No Abstract] [Full Text] [Related]
10. Preliminary investigations on the influence of reserpine therapy on adrenocortical function in schizophrenia. BOSCOTT RJ; JEAVONS M; KAR AB Experientia; 1956 Jul; 12(7):271. PubMed ID: 13344446 [No Abstract] [Full Text] [Related]
11. Comparison of chlorpromazine and reserpine in treatment of schizophrenia; a study of four hundred cases. KURLAND AA AMA Arch Neurol Psychiatry; 1956 May; 75(5):510-3. PubMed ID: 13312733 [No Abstract] [Full Text] [Related]
12. Behavioral changes of chronic schizophrenics in response to reserpine. MCDONALD RE; ELLSWORTH RB; ENISS J AMA Arch Neurol Psychiatry; 1956 Jun; 75(6):575-8. PubMed ID: 13325987 [No Abstract] [Full Text] [Related]
13. Effect of reserpine and open-ward privileges on chronic schizophrenics. PENMAN AS; DREDGE TE AMA Arch Neurol Psychiatry; 1956 Jul; 76(1):42-9. PubMed ID: 13338908 [No Abstract] [Full Text] [Related]
14. [Reserpine, an alkaloid of Rauwolfia serpentina, and its action]. PODLEWSKA A Farm Pol; 1955 Apr; 11(4):80-9. PubMed ID: 13251255 [No Abstract] [Full Text] [Related]
15. Use of reserpine and Rauwolfia in psychoneuroses. FOLKSON A; MAY AR Br Med J; 1955 Nov; 2(4948):1121-2. PubMed ID: 13260677 [No Abstract] [Full Text] [Related]
16. [Treatment of arterial hypertension with Rauwolfia serpentina alkaloids and in particular with reserpine]. RAULE A; LATTUADA A Osp Maggiore; 1955 Jun; 43(6):245-64. PubMed ID: 13254199 [No Abstract] [Full Text] [Related]
17. The effect of reserpine (serpasil) on the chronic disturbed schizophrenic: a comparative study of Rauwolfia alkaloids and electroconvulsive therapy. NAIDOO D J Nerv Ment Dis; 1956 Jan; 123(1):1-13. PubMed ID: 13346356 [No Abstract] [Full Text] [Related]
18. The effects of reserpine on schizophrenic patients. PEARL D; VANDER KAMP H; OLSEN AL; GREENBERG PD; ARMITAGE SG Am J Psychiatry; 1956 May; 112(11):936. PubMed ID: 13313802 [No Abstract] [Full Text] [Related]
19. [Rauwolfia serpentina and reserpine in arterial hypertension]. FERRARA FA; CORTE A Prensa Med Argent; 1955 Jun; 42(22):1612-9. PubMed ID: 13254648 [No Abstract] [Full Text] [Related]
20. Chemotherapeutic trials in psychosis. II. Design and conduct of a trial of raunormine versus reserpine and phenobarbital in chronic schizophrenia. TURNER WJ; CARL A; MERLIS S; WILCOXON F AMA Arch Neurol Psychiatry; 1958 May; 79(5):597-602. PubMed ID: 13519963 [No Abstract] [Full Text] [Related] [Next] [New Search]